Nonprofit drug developer in uphill battle against Trump administration contraception rule change
Medicines360 launched its low-priced contraceptive last year in Madagascar. It is awaiting regulatory approval in Kenya, and it has asked the Nigerian government for a green light.
One country, however, is causing the leaders of the San Francisco-based nonprofit significant angst: the United States.
Proposed rule changes by the Trump administration would limit the availability of and access to Medicines360’s long-acting, reversible intrauterine device, or IUD. While a dec ision could have serious…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Ron Leuty Source Type: news
More News: American Health | Government | Health Management | Kenya Health | Madagascar Health | Nigeria Health | Pharmaceuticals | Trump | USA Health